These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6983870)

  • 1. Immunological follow-up of non-Hodgkin's lymphoma (NHL) in children.
    Bogusławska-Jaworska J; Chybicka A; Pisarek J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):733-8. PubMed ID: 6983870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic status of children with Hodgkin's disease (HD).
    Bogusławska-Jaworska J; Chybicka A; Pisarek J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):725-31. PubMed ID: 6983869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune and phagocytic function in patients on maintenance dialysis and post-transplantation.
    Hosking CS; Atkins RC; Scott DF; Holdsworth SR; Fitzgerald MG; Shelton MJ
    Clin Nephrol; 1976 Dec; 6(6):501-5. PubMed ID: 795582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia.
    Bogusławska-Jaworska J; Chybicka A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):859-66. PubMed ID: 312091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Various parameters of humoral and cellular immunity in children with iron deficiency].
    Guzikowska E; Cholewa Z; Bujniewicź E; Moskała H; Guzikowski K; Madeyski J
    Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):718-9. PubMed ID: 2641796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological status of maculo-anaesthetic leprosy: T and B lymphocytes and serum immunoglobulins.
    Rao SS; Rao TD; Rao PR
    Lepr India; 1982 Jul; 54(3):471-8. PubMed ID: 6983629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].
    Wróbel G; Kazanowska B; Chybicka A; Jeleń M; Małdyk J; Sowińska E; Balcerska A; Balwierz W; Bubała H; Kołakowska-Mrozowska B; Kołtan A; Korzon M; Kowalczyk J; Krawczuk-Rybak M; Maciejka-Kapuścińska L; Matysiak M; Płoszyńska A; Popadiuk S; Solarz E; Sońta-Jakimczyk D; Sopyło B; Stańczak E; Stefaniak J; Stefańska K; Wachowiak J; Wieczorek M; Wysocki M
    Przegl Lek; 2004; 61 Suppl 2():45-8. PubMed ID: 15686045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced natural killer cell activity in non-hodgkin's lymphoma.
    Neri A; Brugiatelli M; Ozger Topuz U; Astaldi G
    Boll Ist Sieroter Milan; 1981 Nov; 60(5):394-407. PubMed ID: 7041921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
    Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
    Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological aspects of pulmonary sarcoidosis].
    Baian A; Blanarikova Z
    Probl Tuberk; 1991; (5):42-3. PubMed ID: 1924242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocyte subpopulations in non-Hodgkin's lymphoma during cytostatic therapy].
    Schnabel I; Fricke HJ; Jansa U; Lehmann G
    Z Gesamte Inn Med; 1979 Dec; 34(23):704-8. PubMed ID: 317767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.
    Opat P; Kolár V; Lauerová L; Pintera J; Zemanová D
    Neoplasma; 1980; 27(3):301-6. PubMed ID: 7453850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
    Pituch-Noworolska A; Miezyński W
    Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity in hypothyroid children (author's transl)].
    Borrajo E; Alpera R; Donat J; Escribano A; Colomer C; Plasencia A; López MJ
    An Esp Pediatr; 1982 May; 16(5):369-76. PubMed ID: 6981366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T and B lymphocytes in the ontogenetic development of man].
    Smogorzewska E; Kunicka A; Siwińska-Gołebiowska H; Chazan B
    Probl Med Wieku Rozwoj; 1981; 10():21-9. PubMed ID: 6984186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
    Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q
    Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.